Ubiquinol

CoQ10 exists in two states: oxidized ubiquinone and reduced ubiquinol. Ubiquinol is marketed as the "active" form that absorbs better. The evidence on that is split. In 12 healthy volunteers taking 200 mg a day for four weeks of each form, ubiquinol raised plasma CoQ10 to 4.3 µg/mL against 2.5 µg/mL for ubiquinone [1]. In a randomized crossover in 21 healthy adults aged 65 to 74, ubiquinol's 1.7-fold advantage over ubiquinone was not statistically significant. A water-soluble ubiquinone syrup beat both [2].

Its most notable clinical result is in multiple-system atrophy, a rare neurodegenerative disease. In a randomized phase 2 trial of 139 patients, high-dose ubiquinol met its primary endpoint, a motor score, and improved daily-living and walking measures, with side-effect rates similar to placebo [3]. Smaller trials found that ubiquinol raised CoQ10 levels in septic shock without changing clinical outcomes [4]. In trained adults it reduced oxidative damage markers from strenuous exercise [5].

Ubiquinol is not a separate receptor agonist; it is CoQ10 carrying two electrons and two protons. In mitochondrial respiration, complex I, complex II and other enzymes reduce ubiquinone to ubiquinol. Ubiquinol diffuses through the inner membrane to complex III, donates its electrons through the Q cycle and becomes ubiquinone again [6]. Its "active form" label therefore misses the point: both oxidation states are required for cycling.

There is a third state, and it is the dangerous one. Oxidized CoQ accepts two electrons to become ubiquinol, but it can also accept them one at a time, passing through the ubisemiquinone radical. That intermediate is not an inert waypoint — it is the source of the superoxide complex III generates at its Qo site, and electrons leaking from reduced CoQ at complex I's Q-binding site during reverse electron transport are a further major ROS source [6]. Describing ubiquinol as the antioxidant form is fair; describing the CoQ pool as an antioxidant system full stop is not.

Where in the Q cycle ubiquinol is consumed. Complex III has two quinone sites. A ubiquinol molecule binds the Qo site near the intermembrane space and is oxidized, sending one electron to the Rieske iron-sulfur protein and on to cytochrome c, and the other across the membrane through two b-type hemes to the Qi site, where a bound ubiquinone is reduced. Two ubiquinol oxidation cycles complete one turn. Each ubiquinol oxidized at Qo releases two protons into the intermembrane space, and two matrix protons are consumed reducing the semiquinone at Qi — which is how electron transfer becomes a proton gradient [6].

As an antioxidant, ubiquinol works by chain-breaking and by regenerating other antioxidants. It donates an electron to a lipid peroxyl radical, yielding a lipid hydroperoxide and a CoQ semiquinone, which quenches a second peroxyl radical and returns to fully oxidized CoQ — two radicals terminated per molecule. It also reduces the vitamin E radical back to vitamin E after vitamin E has done the same job, and, through the plasma-membrane redox system, helps regenerate extracellular ascorbate from the ascorbyl radical [6].

Several enzymes keep the reduced pool topped up in different compartments. At the plasma membrane, FSP1 uses NAD(P)H to regenerate ubiquinol, which limits lipid peroxidation and suppresses ferroptosis; NQO1 and NADH-cytochrome b5 reductase do related work there, and running that cycle regenerates cytosolic NAD+ for glycolysis. In mitochondria, DHODH, glycerol-3-phosphate dehydrogenase and the respiratory chain itself maintain analogous reduced pools [6].

After strenuous exercise, supplementation raised fat-soluble antioxidant status and lowered several oxidative-damage markers [5], but those downstream biomarkers do not establish a distinct clinical outcome.

What taking the reduced form does and does not buy. Taking ubiquinol raised both total blood CoQ10 and the proportion measured in the reduced state in a small crossover, while taking ubiquinone raised total CoQ10 less [1]. But blood redox state is not a measurement of delivery into brain, muscle or mitochondrial membranes — and the cell interconverts the two forms continuously regardless of which one arrives. The reviewed position on the wider question is unhelpful to both products: adding CoQ to cells that are not deficient does not increase respiratory rate, because the normal amount is already sufficient [6], and CoQ10 supplementation did not alter mitochondrial respiration in healthy people [7].

The molecule oxidizes readily, so commercial ubiquinol needs an oxygen-protective softgel or equivalent formulation [8]. That stability engineering, oil carrier, crystal state and dispersion can all affect absorption.

The direct comparisons do not establish ubiquinol as categorically superior. A 12-person four-week crossover favored 200 mg ubiquinol over the same dose of ubiquinone [1]. In 21 older adults, the ubiquinol capsule's 1.7-fold exposure advantage was not statistically significant, while a water-soluble ubiquinone syrup outperformed both capsules [2]. That result is why dosage form should be compared alongside oxidation state.

No side effects were noted in the head-to-head bioavailability study [1]. In the multiple-system atrophy trial, adverse events possibly related to the drug were no more common than on placebo [3].